KauserUl ALAM, Shireen AKTHER, Nazmul SARWAR, Shamsul MORSHED, Goutam Kumar DEBNATH

Prevalence and Antimicrobial Susceptibility of Escherichia Coli O157 Isolated From Raw Milk Marketed in Chittagong, Bangladesh

Escherichia coli is an emerging public health concern in most countries of the world. It is an important cause of food-borne human disease. The present study assessed the prevalence and determined the antibiotic resistance patterns of E. coli from raw milk marketed in Chittagong, Bangladesh. Of the raw milk marketed in Chittagong ~33(18%) of the 186 raw milk samples of it contains E. coli, indicator bacteria for any enteric pathogens. The mean viable count of total bacteria was 4.04×108 cfu/ml and the mean viable count of E. coli in the contaminated raw milk was 1.88×106 cfu/ml. E. coli from only six (18.2%) of the 33 positive samples yielded colourless colonies across the CTSMAC, suggesting the probable presence of populations belonging to the serotype O157 and rest of the isolates 27 (81.82%) produced coloured colony on CT-SMAC considering the probable presence of populations belonging to the serotype non-O157. Growth of probable E. coli O157, as evidenced by the colourless colonies on CT-SMAC compared to coloured colonies from other bacteria. Confirmed isolates were further subjected to antimicrobial susceptibility test using the Agar disc diffusion technique. Antibiotics susceptibility profile showed that all the isolates in case of E. coli O157, penicillin (100%), tetracycline (100%), amoxicillin (83.33%) and erythromycin (83.33%) were the most resistant whereas ciprofloxacin (66.67%), gentamicin (50.0%), and streptomycin (50.0%) were the most sensitive antibiotics. In case of E.coli non-O157 susceptibility profile showed that chloramphenicol (40.74%), erythromycin (40.74%) and oxacillin (37.04%) were the most resistant whereas ciprofloxacin (70.37%), sulphamethoxazole/trimethoprim (S/T) (59.26%) and gentamycin (55.55%) were the most sensitive antibiotics. The antimicrobial resistance exhibited by E. coli O157and nonO157 strains in this study is an indication of possible antibiotic abuse.

PDF

___

Aaku EN, Collinson EK, Gashe BA, Mpuchane S. 2004.Microbiological quality of milk from two processingplantsin Gaborone Botswana. Food Control 15:181– 186.

Aibinu IE, Peters RF, Amisu KO, Adesida SA, Ojo MO, ToluO. 2007. Multidrug Resistance in E. coli O157 Strains and the Public Health Implication. Journal for Animal Science 3(3): 22- 33.

AlHaj N, MarianaNS, Raha AR, Ishak Z. 2007. Prevalence of Antibiotic Resistance AmongEscherichia coli from Different Sources. Malaysia Research Journal of Pharmacology. 1(2): 44- 49.

Arenas R, Gonzales L, Bernardo A, Fresno JM, Tornadijo ME.2004. Microbiological and physic chemical changes in Genestoso cheese, a Spanish acid curd variety, throughout ripening. Food Control 15(4):271–279.

Bertu, WJ, Dapar M, Gusi AM, Ngulukun SS, Leo S,Jwander LD. 2010. Prevalence of brucella antibodies in marketed milk in Jos and environs. African Journal of Food Science 4(2): 62 - 64.

Byrne CM, Erol I, Call JE, Kaspar CW, Buege DR, Hiemke CJ, Fedorka-Cray PJ, Benson AK, Wallace FM,Luchansky JB. 2003. Characterization of Escherichia coli O157:H7 from Downer and Healthy Dairy Cattle in the Upper Midwest Region of the United States. Journal of Applied and Environmental Microbiology 69(8): 4683-4688.

Callaway TR, Anderson RC, Edrington TS, Elder RO, Genovese KJ, Bischoff KM, Poole TL, Jung YS, Harvey RB, Nisbet DJ. 2003. Preslaughter intervention strategies to reduce food-borne pathogens in food animals. Journal of Animal Science 81(2):17-23. Cheesbrough M. 2000. District Laboratory Practice in Tropical Countries.Part 2.United Kingdom: Cambridge University Press, pp 151-220.

Chigor VN, Umoh JV, Smith IS, Igbinosa OE,Okoh IA. 2010. Multidrug Resistance and Plasmid Patterns of Escherichia coli O157 and Other E. coli Isolated from Diarrhoeal Stools and Surface Waters from Some Selected Sources in Zaria, Nigeria. International Journal of Environmental Research and Public Health 7: 3831-3841.

Clinical Laboratory Standards Institute (CLSI). 2005. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-S15 CLSI, Wayne, Chicago, IL, USA. Donkor ES, Aning KG, Quaye J. 2007.Bacterial contaminations of informally marketed raw milk in Ghana.Ghana Medical Journal 41(2): 58 - 61.

Hadrya F, Elouardi A, Benali D, Hami H,Soulaymani A, Senouci S. 2012. Bacterial quality of informally marketed raw milk in Kenitra city, Morocco. Pakistan Journal of Nutrition 11(8):662- 669.

Galland CJ, Hyatt RD, Crupper SS,Acheson W.D. 2001. Prevalence, Antibiotic Susceptibility, and Diversity of E. coli O157:H7 Isolates from a Longitudinal Study of Beef Cattle Feedlots. Journal of Applied and Environmental Microbiology67(4):1619-27.

Goodman AG, Theodore WR, Alan SN,Palmer T. 1990. The Pharmacological Basis of Therapeutics: Eighth edition, US: Pergamon Press. pp. 1020- 1021.

Griffin PM, Tauxe RV. 1991. The Epidemiology of Infections Caused by Escherichia coli O157:H7, Other EnterohemorrhagicE. coli, and the Associated Haemolytic Uremic Syndrome. Epidemiologic Reviews 13: 60-98.

Harrigan WF, MacCance ME. 1976. Laboratory Methods in Food and Dairy Microbiology. 1st edition, London: Academic Press.

Hart A, Ariuki KS. 1998. Antimicrobial Resistance in Developing Countries. British Medical Journal. 317: 647-650.

Kirby WMM, Bauer AW, Sherries JC, Turck M. 1966. Antibiotics Susceptibility Testing. American Journal of Pathology 45: 493- 496.

Lei I, Roffey P, Blanchard C,Gu K. 2008. Development of a multiplex PCR method for the detection of six common foodborne pathogens.Journal of Food and Drug Analysis 16(4): 37 - 43.

Mashood AR, Minga U, Machugun RK. 2006. Current Epidemiologic Status of EnterohaemorrhagicEscherichia coli 0157:H7 in Africa. Chinese Medical Journal 119(3): 217-22.

Metlay, P.J., Powers, H.J., Dudleys, N.M., Christiansen, K. and Finch, G.R. 2006.Antimicrobial Drug Resistance, Regulation and Research.Emerging Infectious Disease Journal.12: 2.

Molbak K, Mead PS, Griffin PM.2002. Antimicrobial Therapy in Patients with Escherichia coli O157:H7 Infection. Journal of American Medical Association 288:1014-6.

Okeke N, Lamikana A, Edelman R. 1995. Socioeconomic and Behaviourial Factors Leading to Acquired Bacterial Resistance in Developing Countries.Emerging Infectious Diseases5:18-27.

Olatoye IO. 2010. The Incidence and Antibiotics Susceptibility of Escherichia coli O157:H7 from Beef in Ibadan Municipal, Nigeria. African Journal of Biotechnology.9(8): 1196-1199.

Parekh TS, Subhash R. 2008.Molecular and bacteriological examination of milk from different milch animals with special reference to Coliforms.Current Research in Bacteriology 1(2): 56-63.

Pierucci O. 1972. Chromosome replication and cell division in Escherichia coli at various temperatures of growth. Journal of bacteriology 109(2):848-854.

Schmidt RH, Goodrich RM, Archer DL, Schneider KR. 2003. General overview of the causative agents of foodborne illness.Institute of Food and Agriculture Sciences. University of Florida, USA.

Schroeder CM, Zhao C, DebRoy C, Torcolini J, Zhao S, White GD, Wagner DD, McDermott FP, Walker DR, Meng J. 2002. Antimicrobial Resistance of Escherichia coli O157:H7 Isolated from Humans, Cattle, Swine, and Food. Journal of Applied and Environmental Microbiology 68: 576–581.

Shitandi A, SternesjöA. 2001. Detection of Antimicrobial Residues in Kenyan Milk.Journal of Food Safety 21: 205-215.

WHO. 2000. Global Principles for the Containment of Antimicrobial Resistance in Animals Intended For Food; Report of WHO Consultation With The Participation Of Food and Agriculture Organization of The United Nation and the Office International Des Epizooties, Geneva Switzerland 5- 9 June 2000. Department of Communicable Disease Surveillance and Response.

Wiking L, Larsen LB, Nielsen JH. 2002. Effects of storage conditions on lipolysis, proteolysis and sensory attributes in high quality raw milk. Milchwissenschaft 57:190–194.

Wong CS, Jelacic S, Habeeb RL, Watkins SL,Tarr PI. 2000. The Risk of the Hemolytic-Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections. New England Journal of Medicine 342:1930-1936.